MLXIPL and obesity due to melanocortin 4 receptor deficiency: The effect of MLXIPL Gln241His on liver disease was most pronounced among those at the highest risk of SLD, namely those with obesity, T2D mellitus, and carriers of PNPLA3 I148M.